News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–32
Matches
32
Sources here
10
Companies here
1
Search results Stored financial headlines

Active search

32 matching headlines

Ticker or company: INBSMain company stories
Clear
Latest

Stock Titan Market update

Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital

Armistice Capital, LLC and Steven Boyd have filed an amended passive ownership report for Intelligent Bio Solutions Inc. (INBS), disclosing a beneficial ownership of 141,397 shares, which represents 5.91% of the common stock. All shares are held with shared voting and dispositive power. Armistice Capital acts as the investment manager for Armistice Capital Master Fund Ltd., the direct …

Main company 🇺🇸 United States
Read at Stock Titan
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
Investing.com Canada Market update Main company 🇺🇸 United States

Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com

This article announces that Intelligent Bio Solutions Inc. filed a Form 8K on August 11. The filing is a standard regulatory disclosure for significant events that shareholders should know about. The brief piece indicates that Investing.com is the source of this financial news.

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Market update Main company 🇺🇸 United States

Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026

Intelligent Bio Solutions (INBS) has completed its multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. All clinical data collection for its FDA 510(k) program is now complete. The company is currently analyzing data and preparing the submission package, aiming for FDA …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Titan Market update Main company 🇺🇸 United States

Intelligent Bio Solutions' Fingerprint Drug Study Enrolled 135

Intelligent Bio Solutions (Nasdaq: INBS) has completed its multi-site Method Comparison Study for the Intelligent Fingerprinting Drug Screening System, enrolling 135 participants across three U.S. sites. This marks the completion of all clinical data collection for its FDA 510(k) submission to detect codeine. The …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
www.marketscreener.com Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions has completed a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System, a crucial step for its FDA 510(k) submission to detect codeine in the U.S. market. The study involved 135 participants across three clinical sites and evaluated the …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Stock News Today

This article provides current stock information for Intelligent Bio Solutions Inc (INBS), including its stock price, market capitalization, and a note that more news will be coming soon. It serves as a placeholder for financial news and analysis for the company. The current stock …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Intelligent Bio Solutions Inc (INBS) has an earnings forecast score of 10.00, ranking 1st in the Biotechnology & Medical Research industry. Analysts have set an average price target of $12.00, with a "Strong Buy" rating from the single analyst covering the stock, indicating a …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track

Intelligent Bio Solutions (INBS) has successfully completed a usability study for its Intelligent Fingerprinting Drug Screening System, demonstrating that non-specialist operators can accurately administer the system. This study, which involved 15 trained operators and followed FDA and ICH GCP standards, supports the company's 510(k) …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Investing.com Market update Main company 🇺🇸 United States

Intelligent Bio Solutions completes usability study for FDA filing

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced the successful completion of a usability study for its Intelligent Fingerprinting Drug Screening System. This study is a critical component of its FDA 510(k) submission for U.S. market clearance, specifically to detect the opiate codeine. The results demonstrated …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training

Intelligent Bio Solutions (Nasdaq: INBS) announced the successful completion of a Usability Study for its Intelligent Fingerprinting Drug Screening System. The study confirmed that 15 non-specialist operators could accurately administer the drug test, supporting its FDA 510(k) submission for U.S. market clearance to detect …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Intelligent Bio Solutions reports 3,018,188 shares outstanding as of July 31, 2026

Intelligent Bio Solutions (INBS) reported 3,018,188 shares of common stock outstanding as of July 31, 2026. This increase in outstanding shares resulted from At The Market (ATM) sales, warrant exercises, and the issuance of restricted shares, including those under an advisory agreement. The company …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Intelligent Bio Solutions drug screen tested against hand creams and dirt

Intelligent Bio Solutions (INBS) has completed an Interference Study for its Intelligent Fingerprinting Drug Screening System, a critical step for its planned FDA 510(k) submission for U.S. market clearance to detect codeine. The study evaluated the system's accuracy when exposed to common substances like …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Manila Times Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

Intelligent Bio Solutions Inc. announced the completion of its Interference Study for the Intelligent Fingerprinting Drug Screening System, a critical step for its FDA 510(k) submission for U.S. market clearance to detect codeine. The study, conducted with CenExel Clinical Research, Inc., assessed the system's …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

INBS|Intelligent Bio Solutions Inc|Price:1.805|Chg%:+0.230

This article provides a comprehensive stock analysis of Intelligent Bio Solutions Inc (INBS) by TradingKey, highlighting its strong fundamentals and high growth potential despite a weak stock market performance. The company, which specializes in non-invasive testing solutions, is considered fairly valued and has received …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Intelligent Bio Solutions Inc (INBS), noting its current risk score of 1.17, which ranks 323 out of 385 in the Biotechnology & Medical Research industry. The company's high beta of 4.21 indicates significant volatility, suggesting outperformance in …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Intelligent Bio Solutions Inc (INBS), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between $2.24 and $1.39, suggesting suitability for range-bound swing trading. While …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Capital return Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Intelligent Bio Solutions Inc (INBS) stock, detailing its latest market performance with a current price of $1.730, along with historical dividend payouts and stock split information. The company has distributed no dividends over the past five years but …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Institutional Confidence

This article from TradingKey provides an overview of Intelligent Bio Solutions Inc (INBS), focusing on its institutional confidence score. The company's stock price and market capitalization are displayed, alongside a table detailing institutional shareholdings and recent changes by key individuals and firms. The institutional …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Analyst action Main company 🇺🇸 United States

INBS|Intelligent Bio Solutions Inc|Price:1.730|Chg%:-0.020

Intelligent Bio Solutions Inc (INBS) is a medical technology company specializing in rapid, non-invasive testing solutions. Despite a recent weak stock market performance, the company exhibits strong fundamentals, high growth potential, and is considered fairly valued by TradingKey. One analyst has rated INBS as …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Intelligent Bio Solutions Inc. Income Statement – GETTEX:12Q

This article presents the income statement for Intelligent Bio Solutions Inc. (GETTEX:12Q), detailing its financial performance. For the last quarter, total revenue increased by 20.25% to €918.15K, although the company reported a net income loss of €2.48M in Q3 26. The statement provides a …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Revenue per share of Intelligent Bio Solutions Inc. – GETTEX:12Q

This article focuses on the "Revenue per share" financial metric for Intelligent Bio Solutions Inc. (GETTEX:12Q). It indicates that the specific financial data for this metric, along with its period, value, and change, is available on the TradingView platform.

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Total equity of Intelligent Bio Solutions Inc. – GETTEX:12Q

This article focuses on the total equity of Intelligent Bio Solutions Inc. (GETTEX:12Q). It appears to be a stub or a placeholder page from TradingView, providing financial data access for the company rather than detailed analytical content. The core information revolves around the company's …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Cash flow from financing activities of Intelligent Bio Solutions Inc. – GETTEX:12Q

This article provides financial information regarding Intelligent Bio Solutions Inc. (GETTEX:12Q), specifically focusing on its cash flow from financing activities. The content appears to be a financial data page from TradingView, showing the company's financial overview and details. No specific values for cash flow …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Intelligent Bio Solutions Inc (INBS) shareholder structure, including major individual and institutional holdings. It lists the top individual shareholders with their respective proportions and recent changes in their holdings, as well as quarterly institutional shareholding data showing …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Intelligent Bio Solutions Inc. Revenue Breakdown – NASDAQ:INBS

Intelligent Bio Solutions Inc. (NASDAQ: INBS) reported total revenue of $3.05 million USD last year. The "Cartridges" segment was the top-performing segment, generating $1.76 million USD. The United Kingdom was the largest regional contributor, accounting for $2.87 million USD in revenue.

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Market update Main company 🇺🇸 United States

Intelligent Bio Solutions addresses cybersecurity issues, keeps 510(k) submission on track for H2 2026

Intelligent Bio Solutions (INBS) has successfully resolved all cybersecurity and software review issues, critical steps for its planned FDA 510(k) submission in the second half of 2026. The company completed independent penetration testing, remediated all high and most low-risk vulnerabilities, and resolved all SBOM …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Quiver Quantitative Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Resolves Final Cybersecurity and Software Review Items Ahead of Planned H2 2026 510(k) Submission

Intelligent Bio Solutions Inc. (INBS) has successfully addressed all cybersecurity and software review items, including remediating medium-risk vulnerabilities and resolving SBOM issues, ahead of its planned FDA 510(k) submission in H2 2026. The company's Intelligent Fingerprinting Drug Screening System targets codeine detection as its …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Fingerprint Drug Test Delivers Results in Under 10 Minutes; FDA Filing Planned

Intelligent Bio Solutions (INBS) announced it has resolved all cybersecurity and software-related review items, including 100% of medium-risk vulnerabilities, for its Intelligent Fingerprinting Drug Screening System. This achievement paves the way for its planned FDA 510(k) submission in calendar H2 2026, targeting codeine detection …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Market update Main company 🇺🇸 United States

Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions announced the successful completion of precision testing for its Intelligent Fingerprinting Drug Screening System. The testing confirmed the system's ability to accurately detect drug traces in fingerprint sweat in under 10 minutes, reinforcing its utility for rapid and non-invasive drug screening. …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Market update Main company 🇺🇸 United States

Intelligent Bio Solutions completes 1,600+ precision tests to bolster FDA 510(k) submission

Intelligent Bio Solutions (INBS) has completed over 1,600 precision tests across multiple sites and production runs to strengthen its FDA 510(k) submission for codeine detection. The tests demonstrated repeatable and reproducible performance, supporting the device's suitability for drug screening. The company plans a U.S. …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Fingerprint Drug Screen Shows Repeatable Results in 1,600 Tests

Intelligent Bio Solutions (Nasdaq: INBS) has completed precision testing for its Fingerprinting Drug Screening System, conducting over 1,600 tests across three production runs and three independent sites. These results demonstrate repeatable and reproducible performance, strengthening the company's FDA 510(k) submission package for clearance to …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Bitget Earnings Main company 🇺🇸 United States

Intelligent Bio Solutions publishes investor deck on fingerprint sweat-based drug screening system

Intelligent Bio Solutions presented details on its fingerprint sweat-based drug screening system, designed for a 16–24 hour detection window to assess potential impairment. The system involves a rapid 5-second fingertip collection and provides results in under 10 minutes, with improvements aiming for 70% faster …

INBS main company
Sharemaestro market context Price below Trend Line 52 weeks -81.3% · Next-week setup negative 36.0% INBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context